Misbah Tahir Igm Biosciences, Inc. (IGMS) insider trading activity

Misbah Tahir is CHIEF FINANCIAL OFFICER of IGM Biosciences, Inc.. Currently has a direct ownership of 90,418 shares of IGMS, which is worth approximately $753,181. The most recent transaction as insider was on Mar 14, 2024, when has been sold 2,543 shares (Common Stock) at a price of $10.17 per share, resulting in proceeds of $25,862. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 90.4K

82.26% 3M change

78.3% 12M change

Total Value Held $753,181

Misbah Tahir Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 14 2024	SELL Open market or private sale	$25,862 $10.17 p/Share	2,543 Reduced 2.74%	90,418 Common Stock
Mar 13 2024	SELL Open market or private sale	$28,622 $9.88 p/Share	2,897 Reduced 3.02%	92,961 Common Stock
Mar 12 2024	BUY Grant, award, or other acquisition	-	46,250 Added 32.55%	95,858 Common Stock
Nov 27 2023	SELL Open market or private sale	$6,765 $5.06 p/Share	1,337 Reduced 2.62%	49,608 Common Stock
Nov 15 2023	BUY Grant, award, or other acquisition	$2,740 $11.71 p/Share	234 Added 0.46%	50,945 Common Stock
May 23 2023	SELL Open market or private sale	$15,938 $12.66 p/Share	1,259 Reduced 2.42%	50,711 Common Stock
May 15 2023	BUY Grant, award, or other acquisition	$4,660 $11.71 p/Share	398 Added 0.76%	51,970 Common Stock

Apr 04 2023	BUY Grant, award, or other acquisition	-	26,250 Added 33.73%	51,572 Common Stock
Mar 14 2023	SELL Open market or private sale	$33,114 $18.73 p/Share	1,768 Reduced 6.53%	25,322 Common Stock
Dec 19 2022	SELL Open market or private sale	$76,020 $20.0 p/Share	3,801 Reduced 12.3%	27,090 Common Stock
Dec 16 2022	SELL Open market or private sale	$43,536 $19.07 p/Share	2,283 Reduced 6.88%	30,891 Common Stock
Nov 23 2022	SELL Open market or private sale	$19,013 $21.68 p/Share	877 Reduced 2.58%	33,174 Common Stock
Nov 15 2022	BUY Grant, award, or other acquisition	$4,532 $12.84 p/Share	353 Added 1.03%	34,051 Common Stock
May 26 2022	SELL Open market or private sale	$16,245 $17.1 p/Share	950 Reduced 2.74%	33,698 Common Stock
May 13 2022	BUY Grant, award, or other acquisition	$4,841 $12.38 p/Share	391 Added 1.12%	34,648 Common Stock
Mar 15 2022	BUY Grant, award, or other acquisition	-	6,084 Added 15.08%	34,257 Common Stock
Mar 12 2022	BUY Grant, award, or other acquisition	-	12,500 Added 30.73%	28,173 Common Stock
Nov 15 2021	BUY Grant, award, or other acquisition	-	10,000 Added 38.95%	15,673 Common Stock
Nov 15 2021	BUY Grant, award, or other acquisition	$4,385 $50.99 p/Share	86 Added 1.49%	5,673 Common Stock
May 14 2021	BUY Grant, award, or other acquisition	$2,066 $45.9 p/Share	45 Added 0.8%	5,587 Common Stock
Mar 05 2021	BUY Exercise of conversion of derivative security	$3,822 $1.39 p/Share	2,750 Added 33.16%	5,542 Common Stock
Dec 21 2020	BUY Exercise of conversion of derivative security	$3,822 $1.39 p/Share	2,750 Added 49.62%	2,792 Common Stock
Nov 13 2020	BUY Grant, award, or other acquisition	$1,909 $45.45 p/Share	42 Added 50.0%	42 Common Stock

Misbah Tahir

CHIEF FINANCIAL OFFICER

Mountain View, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IGMS shares.

Notify only if

Value

Insider Trading

Get notified when an Igm Biosciences, Inc. insider buys or sells IGMS shares.

Notify only if

Operation

Value

Type

News

Receive news related to IGM Biosciences, Inc.

Track Activities on IGMS

Account